These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36983640)

  • 1. Effect of Intravenous Iron Administration on Bone Mineral and Iron Homeostasis in Patients with Inflammatory Bowel Disease-Results of a Prospective Single-Centre Study.
    Tulewicz-Marti E; Szwarc P; Więcek M; Lewandowski K; Korcz T; Cicha M; Rydzewska G
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence of Iron and Vitamin D Deficiencies in Pediatric Patients With Inflammatory Bowel Disease in Bahrain.
    Isa HM; Alahmed FA; Mohamed M; Mohamed A
    Cureus; 2023 Apr; 15(4):e37074. PubMed ID: 37143618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Metabolism Alteration in Patients with Inflammatory Bowel Disease.
    Tulewicz-Marti EM; Lewandowski K; Rydzewska G
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
    Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
    J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.
    Lewerin C; Ljunggren Ö; Nilsson-Ehle H; Karlsson MK; Herlitz H; Lorentzon M; Ohlsson C; Mellström D
    Bone; 2017 May; 98():1-8. PubMed ID: 28212898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23.
    Dahlerup JF; Jacobsen BA; van der Woude J; Bark LÅ; Thomsen LL; Lindgren S
    Scand J Gastroenterol; 2016 Nov; 51(11):1332-8. PubMed ID: 27326766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial.
    Hadji P; Stoetzer O; Decker T; Kurbacher CM; Marmé F; Schneeweiss A; Mundhenke C; Distelrath A; Fasching PA; Lux MP; Lüftner D; Janni W; Muth M; Kreuzeder J; Quiering C; Grischke EM; Tesch H
    J Bone Oncol; 2019 Feb; 14():010-10. PubMed ID: 30515367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low iron status as a factor of increased bone resorption and effects of an iron and vitamin D-fortified skimmed milk on bone remodelling in young Spanish women.
    Toxqui L; Pérez-Granados AM; Blanco-Rojo R; Wright I; de la Piedra C; Vaquero MP
    Eur J Nutr; 2014; 53(2):441-8. PubMed ID: 23771807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early renal impairment affects hormonal regulators of calcium and bone metabolism and Wnt signalling and the response to vitamin D supplementation in healthy older adults.
    Christodoulou M; Aspray TJ; Piec I; Washbourne C; Tang JCY; Fraser WD; Schoenmakers I;
    J Steroid Biochem Mol Biol; 2023 May; 229():106267. PubMed ID: 36739953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone metabolism in cholestatic children before and after living-related liver transplantation--a long-term prospective study.
    Kryskiewicz E; Pawlowska J; Pludowski P; Ismail H; Karczmarewicz E; Teisseyre M; Skorupa E; Ryzko J; Kalicinski P; Socha J; Lorenc RS
    J Clin Densitom; 2012; 15(2):233-40. PubMed ID: 22154432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of administration of dietary supplement with calcium and vitamins D
    Marchenkova LA; Fesyun AD; Gerasimenko MY; Makarova EV
    Vopr Pitan; 2020; 89(5):89-100. PubMed ID: 33211921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease.
    Jahnsen J; Falch JA; Mowinckel P; Aadland E
    Scand J Gastroenterol; 2002 Feb; 37(2):192-9. PubMed ID: 11843057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone density and bone metabolism in patients with inflammatory bowel disease.
    Shirazi KM; Somi MH; Rezaeifar P; Fattahi I; Khoshbaten M; Ahmadzadeh M
    Saudi J Gastroenterol; 2012; 18(4):241-7. PubMed ID: 22824766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose.
    Schaefer B; Zoller H; Wolf M
    J Clin Endocrinol Metab; 2022 Mar; 107(4):1009-1019. PubMed ID: 34850000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of vitamin D administration on inflammatory markers in patients with inflammatory bowel disease.
    Jun JC; Yoon H; Choi YJ; Shin CM; Park YS; Kim N; Lee DH; Kim JS
    Intest Res; 2019 Apr; 17(2):210-217. PubMed ID: 30477283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review.
    Sinnott BP; Licata AA
    Endocr Pract; 2006; 12(6):622-9. PubMed ID: 17229657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.